IDEXX Laboratories IncNASDAQ:IDXX
- LAST PRICE476.4343
- TODAY'S CHANGE (%)0.0343 (0.0072%)
- Bid / Lots476.2600/ 4
- Ask / Lots477.3300/ 4
- Open / Previous Close477.2700 / 476.4000
- Day Range
- 52 Week Range
- Volume82,076
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | IDXX |
|---|---|---|
| 09:32 ET | 5426 | 476.07 |
| 09:34 ET | 500 | 474.195 |
| 09:36 ET | 1125 | 476.475 |
| 09:38 ET | 500 | 477.56 |
| 09:39 ET | 500 | 479.87 |
| 09:41 ET | 586 | 480.75 |
| 09:43 ET | 1330 | 478.04 |
| 09:45 ET | 515 | 477.65 |
| 09:48 ET | 1101 | 478.2 |
| 09:50 ET | 100 | 478.255 |
| 09:52 ET | 100 | 477.16 |
| 09:54 ET | 200 | 477.76 |
| 09:56 ET | 2017 | 475.685 |
| 09:57 ET | 1500 | 476.73 |
| 09:59 ET | 1273 | 475.71 |
| 10:01 ET | 600 | 475.81 |
| 10:03 ET | 4917 | 474.81 |
| 10:06 ET | 1000 | 473.56 |
| 10:08 ET | 200 | 474.885 |
| 10:10 ET | 2089 | 474.93 |
| 10:12 ET | 1100 | 474.66 |
| 10:14 ET | 314 | 474.53 |
| 10:15 ET | 800 | 474.63 |
| 10:17 ET | 575 | 473.94 |
| 10:19 ET | 116 | 474.11 |
| 10:21 ET | 2850 | 473.79 |
| 10:24 ET | 1029 | 474.095 |
| 10:26 ET | 500 | 475.11 |
| 10:28 ET | 2123 | 474.35 |
| 10:30 ET | 800 | 474.79 |
| 10:32 ET | 366 | 474.75 |
| 10:33 ET | 100 | 475.17 |
| 10:37 ET | 727 | 477.035 |
| 10:39 ET | 300 | 477.23 |
| 10:44 ET | 200 | 476.155 |
| 10:46 ET | 100 | 475.5 |
| 10:48 ET | 300 | 475.47 |
| 10:51 ET | 300 | 476.68 |
| 10:57 ET | 1300 | 476.66 |
| 11:00 ET | 210 | 476.4343 |
Jun 24, 2024
IDEXX Laboratories to Release 2024 Second Quarter Financial Results, from 11:00AM ET on Monday Jun 24, 2024 by Dow Jones
11:00AM ET on Monday Jun 24, 2024 by Dow JonesDJ IDEXX Labs Is Maintained at Hold by Stifel, from 9:05AM ET on Monday Jun 24, 2024 by Dow Jones
9:05AM ET on Monday Jun 24, 2024 by Dow Jones
Jun 4, 2024
IDEXX Expands Test Menu for the Catalyst Platform to Support Veterinarians Globally in Diagnosing Pancreatitis, from 7:00AM ET on Tuesday Jun 04, 2024 by Dow Jones
7:00AM ET on Tuesday Jun 04, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
IDEXX Laboratories Inc | 39.3B | 46.2x | +18.62% |
Dexcom Inc | 44.6B | 74.1x | --- |
Mettler-Toledo International Inc | 29.2B | 38.5x | +12.39% |
West Pharmaceutical Services Inc | 23.6B | 43.0x | +23.79% |
STERIS plc | 21.6B | 39.4x | +9.33% |
Zimmer Biomet Holdings Inc | 21.8B | 22.9x | --- |
Company Information
IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. Its Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. Its LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve the quality and safety of milk.
Contact Information
- Headquarters
- One Idexx DriveWESTBROOK, ME, United States 04092-2041
- Phone
- 207-556-0300
- Fax
- 207-556-4346
Executives
- Independent Chairman of the Board
- Lawrence Kingsley
- President, Chief Executive Officer, Director
- Jonathan Mazelsky
- Chief Financial Officer, Executive Vice President, Treasurer
- Brian Mckeon
- Chief Human Resource Officer, Executive Vice President
- Michael Johnson
- Executive Vice President, Chief Technology Officer
- Martin Smith
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $39.3B |
|---|---|
Revenue (TTM) | $3.7B |
Shares Outstanding | 82.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.32 |
EPS | $10.32 |
Book Value | $17.88 |
P/E Ratio | 46.2x |
Price/Sales (TTM) | 10.6 |
Price/Cash Flow (TTM) | 40.0x |
Operating Margin | 29.95% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
